| Literature DB >> 36046788 |
Natália Yumi Noronha1, Guilherme da Silva Rodrigues1, Isabella Harumi Yonehara Noma2, Camila Fernanda Cunha Brandao1,3, Karine Pereira Rodrigues1, Alexandre Colello Bruno4, Chanachai Sae-Lee5, Lígia Moriguchi Watanabe6, Marcela Augusta de Souza Pinhel1,7, Isabelle Mello Schineider6, Mariana Luciano de Almeida8, Fernando Barbosa Júnior9, Déborah Araújo Morais9, Wellington Tavares de Sousa Júnior9, Torsten Plösch10, Carlos Roberto Bueno Junior1,11, Carla Barbosa Nonino1,6.
Abstract
Background: Pre-diabetes precedes Diabetes Mellitus (DM) disease and is a critical period for hyperglycemia treatment, especially for menopausal women, considering all metabolic alterations due to hormonal changes. Recently, the literature has demonstrated the role of physical exercise in epigenetic reprogramming to modulate the gene expression patterns of metabolic conditions, such as hyperglycemia, and prevent DM development. In the present study, we hypothesized that physical exercise training could modify the epigenetic patterns of women with poor glycemic control.Entities:
Keywords: DNA methylation; combined physical exercise; epigenomics; older women; physical exercise
Mesh:
Year: 2022 PMID: 36046788 PMCID: PMC9423096 DOI: 10.3389/fendo.2022.895489
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 6.055
Mean ± standard deviation of anthropometric, blood pressure, and biochemical variables pre and post-14 weeks of combined training (PG: n = 24; NGG: n = 24).
| Variables | Group | PRE | POST | p (group) | p (time) | p (group x time) |
|---|---|---|---|---|---|---|
| Age (years) | PG | 61.3±5.2 | 0.184 | |||
| NGG | 59.9±4.8 | |||||
|
| ||||||
| Stature (m) | PG | 1.6±0.1 | 0.199 | |||
| NGG | 1.6±0.1 | |||||
| BM (kg) | PG | 74.2±12.3 | 74.2±11.6 | 0.229 | 0.858 | 0.848 |
| NGG | 70.3±8.2 | 70.2±8.0 | ||||
| BMI (kg/m2) | PG | 30.7±4.2 | 30.1±4.2 | 0.223 | 0.188 | 0.892 |
| NGG | 28.2±3.2 | 27.8±2.8 | ||||
| WC (cm) | PG | 95.2±11.1 | 98.3±12.6 | 0.278 | 0.728 | 0.081 |
| NGG | 94.1±10.3 | 92.2±9.4 | ||||
| HC (cm) | PG | 108.5±8.8 | 106.2±10.0 | 0.166 | 0.386 | 0.139 |
| NGG | 103.6±7.3 | 104.2±6.2 | ||||
|
| ||||||
| SBP (mmHg) | PG | 140.9±20.1 | 126.7±15.1 | <0.001# | <0.001* | 0.192 |
| NGG | 123.7±9.6 | 115.5±9.0 | ||||
| DBP (mmHg) | PG | 82.0±12.3 | 77.7±8.5 | 0.003# | 0.016* | 0.48 |
| NGG | 74.0±6.7 | 71.6±5.4 | ||||
|
| ||||||
| Uric acid (mg/dL) | PG | 4.3±1.2 | 4.5±1.3 | 0.234 | 0.187 | 0.928 |
| NGG | 4.0±1,1 | 4.1±1.0 | ||||
| Cholesterol (mg/dL) | PG | 220.2±37.0 | 207.2±38.1 | 0.614 | 0.010* | 0.909 |
| NGG | 212.8±33.1 | 201.9±29.1 | ||||
| Glucose (mg/dL) | PG | 115.1±24.0 | 104.9±12.0 | <0.001# | 0.23 | 0.05 |
| NGG | 92.7±4.6 | 95.4±7.4 | ||||
| HDL (mg/dL) | PG | 50.7±9.4 | 48.9±8.9 | 0.026# | 0.006* | 0.114 |
| NGG | 59.9±14.1 | 53.3±11.7 | ||||
| LDL (mg/dL) | PG | 135.6±37.1 | 131.1±37.3 | 0.299 | 0.198 | 0.848 |
| NGG | 127.4±30.6 | 119.9±40.8 | ||||
| Triglycerides (mg/dL) | PG | 152.9±49.1 | 131.6±36.0 | 0.073 | 0.001* | 0.654 |
| NGG | 128.3±50.5 | 112.1±38.0 | ||||
| Insulin UI/ml | PG | 14.1±11.9 | 14.9±10.0 | 0.052 | 0.108 | 0.694 |
| NGG | 8.8±4.9 | 10.5±5.1 | ||||
| HOMAR IR | PG | 71.5±63.8 | 71.7±54.3 | 0.018# | 0.316 | 0.338 |
| NGG | 36.4±19.6 | 44.7±22.7 | ||||
BMI, body mass index; WC, waist circumference; HC, hip circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoproteins LDL, low-density lipoproteins; CM, centimeters; mmHg, millimeters of mercury; kg, kilogram; m, meters; PG, prediabetes group; NGG, normal glucose group. *statistical difference time; #statistical difference group; p < 0.05 for pre versus post (repeated measures two-way ANOVA was used).
Mean ± standard deviation of the PRE AND POST motor variables 14 weeks of combined training (PG: n 24; NGG: n 24).
|
|
|
|
|
|
|
|
| EFE (repetitions) | PG | 18.5 ± 4.3 | 21.8 ± 4.4 | 0.705 | <0.001* | 0.929 |
| NGG | 18.2 ± 3.7 | 21.3 ± 3.4 | ||||
| SAS (repetitions) | PG | 14.5 ± 4.5 | 18.4 ± 6.1 | 0.363 | <0.001* | 0.880 |
| NGG | 13.7 ± 3.5 | 17.3 ± 4.2 | ||||
| Agility (sec) | PG | 26.6 ± 3.2 | 23.4 ± 3.6 | 0.253 | <0.001* | 0.285 |
| 6MWT (m) | PG | 540.3 ± 67.1 | 572.4 ± 60.3 | 0.905 | <0.001* | 0.257 |
EFE, elbow flexion and extension; SAS, sit and stand; sec, seconds; m, meters; PG, prediabetes group; NGG, normal glucose group. *statistical difference time; p < 0.05 for pre versus post (repeated measures two-way ANOVA was used).
Mean ± standard deviation of PRE and POST metal values 14 weeks of combined training (PG: n 24; NGG: n 24).
|
|
|
|
|
|
|
|
| Hg | PG | 0.06 ± 0.1 | 0.03 ± 0.1 | 0.651 | 0.030* | 0.651 |
| NGG | 0.05 ± 0.1 | 0.02 ± 0.1 | ||||
| Al | PG | 184.3 ± 150.7 | 159.5.1 ± 154.8 | 0.46 | 0.476 | 0.907 |
| NGG | 152.2 ± 177.5 | 135.0 ± 59.0 | ||||
| As | PG | 2.9 ± 0.4 | 2.9 ± 0.2 | 0.386 | 0.818 | 0.181 |
| NGG | 2.7 ± 0.2 | 3.0 ± 0.0 | ||||
| Cd | PG | 0.2 ± 0.8 | 0.03 ± 0.0 | 0.391 | 0.212 | 0.452 |
| NGG | 0.8 ± 0.0 | 0.02 ± 0.0 | ||||
| Pb | PG | 2.1 ± 1.6 | 1.1 ± 0.3 | 0.385 | 0.001* | 0.33 |
| NGG | 1.7 ± 0.8 | 1.1 ± 0.0 | ||||
| Ni | PG | 6.3 ± 1.0 | 5.3 ± 1.3 | 0.175 | 0.44 | 0.879 |
| NGG | 4.4 ± 2.4 | 3.0 ± 0.8 | ||||
| Li | PG | 0.6 ± 0.3 | 0.5 ± 0.1 | 0.492 | 0.104 | 0.934 |
| NGG | 0.6 ± 0.3 | 0.5 ± 0.2 |
Hg, mercury; Al, aluminum; As, arsenic; Cd, cadmium; Pb, lead; Ni, nickel; Li, lithium; PG, prediabetes group; NGG, normal glucose group. *statistical difference time; p < 0.05 for pre versus post (repeated measures two-way ANOVA.
Figure 1Differences in epigenetic age in PRE and POST comparisons 14 weeks of combined training. PG, prediabetes group; NGG, normal glucose group; EEAA, extrinsic epigenetic age acceleration; IEAA, intrinsic epigenetic age acceleration; Pre and pos-intervention comparison for the epigenetic clock in the PG group (panels A–C). Pre and post-intervention comparison for the epigenetic clock in the NGG group (panels D–F). (repeated measures two-way ANOVA was used). The presented values were not statically different between groups.
Differentially Methylated Regions (DMRs) of the Prediabetes Group (PG) compared to the Normal Glucose Group (NGG) before 14 weeks of physical activity intervention.
|
|
|
|
|
|
| 0.534 | 0.723 |
| -0.19 | <0.001 |
| 0.5 | 0.579 |
| -0.08 | 0.013 |
| 0.25 | 0.317 |
| -0.07 | 0.023 |
| 0.743 | 0.806 |
| -0.06 | 0.015 |
| 0.747 | 0.784 |
| -0.04 | 0.026 |
| 0.199 | 0.231 |
| -0.03 | 0.005 |
| 0.565 | 0.595 |
| -0.03 | <0.001 |
| 0.104 | 0.131 |
| -0.03 | 0.014 |
| 0.06 | 0.07 |
| -0.01 | 0.007 |
| 0.045 | 0.035 |
| 0.01 | 0.004 |
| 0.059 | 0.049 |
| 0.01 | 0.008 |
| 0.451 | 0.364 |
| 0.09 | 0.005 |
Differentially Methylated Regions (DMRs) of the Prediabetes Group (PG) compared to the Normal Glucose Group (NGG) before 14 weeks of physical activity intervention.
|
|
|
|
|
|
| 0.699 | 0.495 |
| -0.2 | <0.001 |
| 0.259 | 0.188 |
| -0.07 | 0.012 |
| 0.078 | 0.064 |
| -0.01 | 0.004 |
| 0.592 | 0.585 |
| -0.01 | 0.001 |
| 0.036 | 0.048 |
| 0.01 | <0.001 |
Differentially Methylated Regions (DMRs) from the PGpost compared to the PGpre after 14-week physical intervention activity.
|
|
| ||||
|---|---|---|---|---|---|
| Gene | p-value | Gene | p-value | ||
| 0.043 |
| 0.004 | -0.009 |
| 0.008 |
| 0.011 |
| 0.024 | -0.009 |
| 0.021 |
| 0.003 |
| 0.024 | -0.009 |
| 0.02 |
| 0 |
| 0.022 | -0.009 |
| 0.005 |
| -0.001 |
| 0.035 | -0.009 |
| 0.011 |
| -0.001 |
| 0.024 | -0.009 |
| 0.024 |
| -0.001 |
| 0.014 | -0.009 |
| 0.02 |
| -0.001 |
| 0.006 | -0.009 |
| 0.031 |
| -0.001 |
| 0.01 | -0.009 |
| 0.028 |
| -0.002 |
| 0.01 | -0.01 |
| 0.022 |
| -0.002 |
| 0.03 | -0.01 |
| 0.004 |
| -0.003 |
| 0.02 | -0.01 |
| 0.011 |
| -0.003 |
| 0.019 | -0.01 |
| 0.022 |
| -0.003 |
| 0.013 | -0.01 |
| 0.026 |
| -0.003 |
| 0.008 | -0.01 |
| 0.016 |
| -0.004 |
| 0.005 | -0.01 |
| 0.015 |
| -0.004 |
| 0.02 | -0.01 |
| 0.021 |
| -0.004 |
| 0.008 | -0.01 |
| 0.004 |
| -0.005 |
| 0.012 | -0.011 |
| 0.032 |
| -0.005 |
| 0.023 | -0.011 |
| 0.019 |
| -0.005 |
| 0.009 | -0.011 |
| 0.014 |
| -0.005 |
| 0.007 | -0.012 |
| 0.007 |
| -0.005 |
| 0.008 | -0.012 |
| 0.017 |
| -0.005 |
| 0.011 | -0.012 |
| 0.013 |
| -0.005 |
| 0.011 | -0.012 |
| 0.009 |
| -0.005 |
| 0.021 | -0.012 |
| 0.015 |
| -0.005 |
| 0.016 | -0.013 |
| 0.017 |
| -0.006 |
| 0.015 | -0.013 |
| 0.023 |
| -0.006 |
| 0.028 | -0.013 |
| 0.007 |
| -0.006 |
| 0.01 | -0.013 |
| 0.024 |
| -0.006 |
| 0.01 | -0.013 |
| 0.008 |
| -0.006 |
| 0.004 | -0.013 |
| 0.012 |
| -0.006 |
| 0.026 | -0.013 |
| 0.027 |
| -0.007 |
| 0.004 | -0.014 |
| 0.022 |
| -0.007 |
| 0.013 | -0.014 |
| 0.027 |
| -0.007 |
| 0.012 | -0.014 |
| 0.032 |
| -0.007 |
| 0.025 | -0.015 |
| 0.015 |
| -0.007 |
| 0.002 | -0.015 |
| 0.006 |
| -0.007 |
| 0.015 | -0.015 |
| 0.002 |
| -0.007 |
| 0.029 | -0.015 |
| 0.017 |
| -0.007 |
| 0.015 | -0.015 |
| 0.024 |
| -0.007 |
| 0.003 | -0.015 |
| 0.015 |
| -0.007 |
| 0.01 | -0.017 |
| 0.004 |
| -0.007 |
| 0.003 | -0.017 |
| 0.007 |
| -0.008 |
| 0.007 | -0.019 |
| 0.009 |
| -0.008 |
| 0.005 | -0.019 |
| 0.005 |
| -0.008 |
| 0.011 | -0.019 |
| 0.011 |
| -0.008 |
| 0.005 | -0.02 |
| 0.011 |
| -0.008 |
| 0.025 | -0.02 |
| 0.004 |
| -0.008 |
| 0.006 | -0.02 |
| 0.01 |
| -0.008 |
| 0.018 | -0.02 |
| 0.011 |
| -0.009 |
| 0.004 | -0.02 |
| 0.012 |
| -0.009 |
| 0.018 | -0.022 |
| 0.004 |
| -0.009 |
| 0.027 | -0.022 |
| 0.011 |
| -0.009 |
| 0.028 | -0.022 |
| 0.011 |
| -0.009 |
| 0.011 | -0.024 |
| 0.01 |
| -0.009 |
| 0.009 | -0.028 |
| 0.003 |
| -0.009 |
| 0.005 | -0.033 |
| 0.008 |
| -0.009 |
| 0.02 | -0.048 |
| 0.018 |
Figure 2Singular Value Decomposition Analysis (SVD). Note: Pb: lead; Hg: mercury.
Figure 3The intersection of Differently Methylated Regions of the prediabetes group (PG) between post-intervention, lead (Pb), and glucose. BRCA1 gene is related to 14-week intervention and glucose. SLFN12 gene is related to glucose and lead (Pb).
Figure 4Representation of the pathways possibly influenced by differentially methylated regions (DMRs) in PG vs. NGG.
Figure 5Representation of the pathways influenced possibly by hypermethylated regions in PG after the 14-week physical exercise intervention.
Figure 6Representation of the functions possibly influenced by hypomethylated regions in PG after the 14-week physical exercise intervention. The Functional Annotation was done using the Genecards Database and literature text mining.